3165:HK:HK-ChinaAMC MSCI Europe Quality Hedged to USD ETF (HKD)

ETF | Others |

Last Closing

USD 18.3

Change

-0.22 (-1.19)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+1.32 (+6.05%)

USD 161.07B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+5.58 (+7.29%)

USD 20.18B
2801:HK iShares Core MSCI China ETF

+1.94 (+8.62%)

USD 17.71B
2823:HK iShares FTSE A50 China

+1.04 (+6.90%)

USD 14.19B
83188:HK ChinaAMC CSI 300 Index ETF

+4.60 (+10.98%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.11 (+8.84%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.85 (+8.51%)

USD 9.22B
82822:HK CSOP FTSE China A50

+1.07 (+8.41%)

USD 7.65B
9010:HK iShares Core MSCI AC Asia ex J..

+0.13 (+1.69%)

USD 3.03B

ETFs Containing 3165:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.25% 56% F 60% D-
Dividend Return 0.24% 9% A- 1% F
Total Return 9.49% 54% F 57% F
Trailing 12 Months  
Capital Gain 16.56% 62% D 65% D
Dividend Return 1.85% 20% F 15% F
Total Return 18.41% 61% D- 64% D
Trailing 5 Years  
Capital Gain 55.61% 77% C+ 82% B
Dividend Return 6.04% 43% F 20% F
Total Return 61.65% 77% C+ 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 9.68% N/A N/A 74% C
Dividend Return 10.81% N/A N/A 72% C
Total Return 1.13% N/A N/A 26% F
Risk Return Profile  
Volatility (Standard Deviation) 12.85% N/A N/A 88% B+
Risk Adjusted Return 84.14% N/A N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike